论文信息 - Sequential Cytarabine and Alpha-Particle Immunotherapy with Bismuth-213 (213Bi)-Labeled-HuM195 (Lintuzumab) for Acute Myeloid Leukemia (AML) - 字舞流文

Sequential Cytarabine and Alpha-Particle Immunotherapy with Bismuth-213 (213Bi)-Labeled-HuM195 (Lintuzumab) for Acute Myeloid Leukemia (AML)

S. Larson | D. Scheinberg | M. McDevitt | M. Heaney | N. Pandit-Taskar | J. Jurcic | A. Morgenstern | M. Weiss | D. Mulford | T. Rosenblat | S. Chanel